An affiliate of Ant Financial has taken a 30% stake in the campus information platform operator, a spinout of Newcapec Electronics, following a $36.5m investment.

Keros Therapeutics will use the proceeds from the Partners Healthcare and Medison Pharma-backed round to push its rare muscle disease drugs into clinical trials.

The Intel Capital-backed pharmaceutical e-commerce platform has begun raising a new funding round that would reportedly value the company at $200m.

Sunfire, a provider of gas and fuel production equipment, has received $28.8m in a round led by new strategic partner Paul Wurth that included corporates CEZ and Total.

Johnson Controls, Airbus, Lockheed Martin and Sumitomo combined for a round that will fund an expansion of the location technology developer's production.

Genomics tool developer 10x Genomics has raised $35m that will be combined with the $50m SoftBank-backed first close it achieved in April.

Hill-Rom and Wells Fargo have co-led the medical monitoring device maker's latest round, taking its total funding to almost $140m.

The Cisco and Deutsche Telekom-backed video advertising software provider has received capital from Goldman Sachs that it described as pre-IPO funding.

ETH Zurich spinouts lifted their total funding haul to $173.3m from $123.1m in 2017.

NantCell received the funding at a $4bn valuation, giving existing investor Celgene a 2.8% stake in the cancer immunotherapy developer.